Healthcare Stocks Ending With Broad Gains; Stereotaxis Rises After Completing Clinical Trial of Surgical Device

By Staff,

Shutterstock photo

Top Healthcare Stocks

JNJ +2.13%

PFE +0.82%

ABT -0.79%

MRK +0.76%

AMGN +2.63%

Healthcare stocks are rising today with the NYSE Healthcare Sector Index up nearly 1.2% and shares of healthcare companies in the S&P 500 gaining 1.1% as a group.

In company news, Stereotaxis Inc. ( STXS ) rose as much as 31% today after saying it has completed clinical testing required for FDA acceptance of the company's Vdrive Robotic navigation system with V-Loop circular catheter manipulator.

Results of the 120-patient study conducted at three Stereotaxis sites in the U.S. and two in Europe will be included in a 510(k) Premarket Notification STXS expects to submit to agency before the end of March.

STXS shares were up about 16.3% in late trade at $4.65 after earlier rising to an intra-day high of $5.24 a share.

In other sector news,

(+) EPZM, Earns $25 mln milestone payment from Celgene ( CELG ) after achieving proof of concept with the EPZ-5676 DOT1L inhibitor clinical program now in Phase I testing in patients with translocations of the MLL gene. CELG also rose today.

(-) SRPT, Continued weakness after a Citigroup analyst yesterday questioned whether the company's drug for Duchenne muscular dystrophy eventually will be approved by U.S. regulators. The stock fell 8% yesterday.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2014 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing Commodities
Referenced Stocks: CELG , STXS

More from MT Newswires


MT Newswires

MT Newswires

Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by